Cystic Fibrosis Foundation
Overview
Cystic Fibrosis Foundation is a non-profit organization that provides early-stage funding to companies to develop breakthrough drugs for cystic fibrosis through a venture philanthropy model.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SpliSense | Jun 2026 | Grant | Lead |
| Anagram Therapeutics Inc. | May 2026 | Early Funding | Co-investor |
| ReCode Therapeutics | Sep 2025 | Grant | Co-investor |
| SNIPR Biome | Aug 2025 | Series B | Co-investor |
| Owlstone Medical | Mar 2025 | Corporate Funding | Lead |
Key People
Bob Derr
Founder Secretary Public Relations
Jennifer McKinnon
Jennifer S Journey Founder President
Laurie Hutchison
Founder Chairperson Destin Great Strides
Eric Koehrsen
Managing Director, Investments
Regina Schewe
Managing Director Major Gifts
Derrick Mueller
Network Leadership Team - Parent Partner
Janeil Whitworth
Cystic Fibrosis Learning Network-Family Patient Partner
Bethany Warren
Senior Strategy Principal
Chris Wirtalla
Senior Principal Data Manager Clinical Data Wrangler
Erin Mellen
Internal Audit Principal
Hillary Valley
Principal, Mission Ventures
Julia Caponiti
Senior Strategy Principal
Lauren Katz
Clinical Program Research Principal
Michael Lee
Strategy Principal
Shelby Murrin
Strategy Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
